JIVA PEAK
LIVE

Serial Number

79391459

Owner

Apeiron Investment Group Ltd

Attorney

Andrew D. Skale

Filing Date

Dec 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

JIVA PEAK Trademark

Serial Number: 79391459 • Registration: 7846418

JIVA PEAK is a trademark filed by Apeiron Investment Group Ltd on December 5, 2023. The trademark is classified under Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Apeiron Investment Group Ltd (6 trademarks)

Beatrice, 66 & 67 Amery Street

Entity Type: 99

Trademark Details

Filing Date

December 5, 2023

Registration Date

July 1, 2025

Published for Opposition

May 13, 2025

Goods & Services

Business data analysis, research and information services; commercial trade and consumer information, namely, providing consumer information via a website; business assistance, management and administration services; advertising, marketing and promotional services; commercial services and consumer information, namely retailing and wholesaling, including via the internet, in the nature of retail and wholesale store services featuring medicines, medical technology apparatus and devices, veterinary preparations, apparatus and devices, chemicals, foodstuffs, sanitary articles, agricultural products, animal food; business process management; business administration and management; administration of foreign business affairs; business administration of sales and promotional incentive schemes; business management assistance; consultancy regarding the organization or managing of a trade company; professional business consultancy; professional business consultancy, the aforesaid services for biotech companies; advisory services for business management; business risk management services; business management consultancy; consultancy services regarding business strategies; public relations services; business consulting services for start-up companies; advertising services relating to pharmaceutical products; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; business acquisitions consultation; business management consultancy and advisory services, the aforesaid services for biotech companies; consultancy and advisory services in the field of business strategy, the aforesaid services in particular for biotech companies; creative marketing plan development services, the aforesaid services in particular for biotech companies; development of marketing concepts, the aforesaid services in particular for biotech companies

Prosthetic ligaments and artificial breast implants; orthopedic and mobility aids, namely, walkers to aid in mobility; medical and veterinary apparatus and instruments, namely, medical and veterinary ultrasound apparatus; physical therapy equipment, namely, Manually-operated exercise equipment for physical therapy purposes

Educational instruction in the field of business; horse training; conducting of seminars and workshops in the fields of health, pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; publishing scientific papers in relation to medical technology; organisation of conferences and symposia in the field of medical science; publishing scientific papers in relation to medical technology

Financial advisory services, and banking; real estate valuation services; charitable fundraising and financial sponsorship of sporting events; real estate financing services; medical insurance underwriting; pawn brokerage; hedge fund management services; hedge fund investment services; hedge fund management; investment asset management services; financial planning and management; venture capital fund management; investment portfolio management services; financial management of funds; capital investment services; investment fund management; investment consultancy; development of investment portfolios being investment management services; financial management; wealth management services; financial investment advisory services; real estate escrow services; financial investment advisory services, the aforesaid services in particular for biotech companies; mutual funds; financing and funding services, namely, Venture capital funding services to emerging and start-up companies; financial advice and consultancy services; project financing; financing of development projects; financial and monetary transaction services, namely, Credit card transaction processing services; assistance in the nature of financial advice relating to purchase and financial investment relating to real estate, in particular for biotech companies; equity financing services; capital funding in the nature of venture capital funding services to emerging and start-up companies, the aforesaid services in particular for biotech companies

Preparation and dispensing of medications; providing medical information relating to the preparation and dispensing of medications; beauty care services; animal healthcare services; human healthcare services; horticulture services; dentistry services; medical services; health counselling; pharmaceutical compounding services; provision of pharmaceutical information, namely, Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical consultancy and information services relating to pharmaceutical products.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 27, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 27, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 1, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 29, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 13, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 13, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 1, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 13, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 13, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 13, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 13, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 13, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 12, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 12, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 12, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 30, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 3, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 2, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 2, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 7, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 7, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 7, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 7, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 7, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 14, 2024 REPR